One of the most common fitness objectives in the world is losing weight, but it’s not always easy to achieve. To make it sustainable, it is a multifaceted process that involves proper food and exercise.
A number of pharmaceuticals have gained popularity in recent years as weight-loss aids that give users a quick route to their goal. Among these, Mounjaro and Ozempic are two of the most well-known brands.
Despite having access to the best lifestyle and health advice, many celebrities worldwide have turned to using the medication, which is why it is so popular. Additionally, comedian Aishwarya Mohanraj gave Mounjaro credit for her significant weight loss earlier this week.
Soha Ali Khan’s take on Ozempic and Mounjaro
On February 11, Soha Ali Khan commended Aishwarya on Instagram for her bravery in being honest about her weight loss experience.
At last, someone stated it. They shed a significant amount of weight by using Mounjaro in addition to exercising and eating healthily. And speaking the truth, in my opinion, requires a lot of bravery, the actor stated.
She drew attention to another section of Aishwarya’s speech in which the comedian advised people to see doctors before using weight loss medications rather than relying on her or other influencers for guidance.
According to Soha, Ozempic and Mounjaro aren’t weight loss trends. They are only intended for specific individuals and are serious medical treatments.
She acknowledged that losing weight might occasionally be difficult and that desire alone cannot guarantee success. A number of additional components are involved, such as thyroid, metabolism, PCOS, insulin resistance, and hormones.
Although they are dangerous and have negative effects, injections can be helpful. They require examinations and medical oversight, Soha emphasized. Therefore, we should ask ourselves, who really needs it, rather than, who is taking it?
In order to dispel the science, the risks, and the myths surrounding these medications, the actor announced that she will be joined by nutritionist Dr. Juhi Agarwal and one of India’s top endocrinologists, Dr. Ambrish Mithal, in the next episode of her podcast All About Her, which airs on Friday, February 13.
Are Mounjaro and Ozempic the same drug?
Both Mounjaro and Ozempic have gained popularity as weight-loss medications that work impressively quickly. There are notable distinctions between the two, despite their many similarities.
WebMD states that both medications are GLP-1 agonists, a class of medications that mimic the small intestine’s production of the hormone glucagon-like peptide 1 (GLP-1).
In addition to lowering blood sugar levels by encouraging the body to create more insulin, the hormone and medications also prolong the time that food remains in the stomach, which reduces hunger.
Tirzepatide is the generic name for Mounjaro. It is given to treat type 2 diabetes and is an agonist of the GLP-1 and GIP (gastric inhibitory polypeptide) receptors.
On the other hand, the generic name for Ozempic is Semaglutide. It is a GLP-1 receptor agonist, and is prescribed for adults with diabetes and known heart disease.
Soha pointed out that Ozempic and Mounjaro are not weight loss fads. They are only intended for specific individuals and are serious medical treatments.
The actor revealed that willpower isn’t the only factor in weight loss. The procedure might be impacted by numerous health conditions. Thyroid problems, PCOS, insulin resistance, hormones, and metabolism all have an impact.
Also Read: Russia Bans WhatsApp in Move Affecting 100 Million Users; Will Ban Be Reversed?
Although they are dangerous and have negative effects, injections can be helpful. The actor emphasized that they require medical care and testing. Therefore, we should ask ourselves, who really needs it, rather than, who is taking it?
She also disclosed that this subject will be the main focus of her next All About Her podcast episode, which will be released on Friday.
